{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T18:35:53Z","timestamp":1694630153870},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1007\/s11936-001-0027-4","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T08:10:29Z","timestamp":1180858229000},"page":"371-383","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pediatric primary pulmonary hypertension"],"prefix":"10.1007","volume":"3","author":[{"given":"Andrew J.","family":"Maxwell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy D.","family":"Bridges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"27_CR1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","volume":"115","author":"GE D\u2019Alonzo","year":"1991","unstructured":"D\u2019Alonzo GE, Barst RJ, Ayers SM, et al.: Survival in patients with primary pulmonary hypertension: results from a National Prospective Registry. Ann Int Med 1991, 115:343\u2013349.","journal-title":"Ann Int Med"},{"key":"27_CR2","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/S0735-1097(97)00155-1","volume":"30","author":"ML Clabby","year":"1997","unstructured":"Clabby ML, Canter CE, Moller JH, et al.: Hemodynamic data and survival in children with pulmonary hypertension. J Am Coll Cardiol 1997, 30:554\u2013560.","journal-title":"J Am Coll Cardiol"},{"key":"27_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/ng0397-277","volume":"15","author":"WC Nichols","year":"1997","unstructured":"Nichols WC, Koller DL, Slovis B, et al.: Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32. Nat Genet 1997, 15:277\u2013280.","journal-title":"Nat Genet"},{"key":"27_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1056\/NEJM199507273330403","volume":"333","author":"A Giaid","year":"1995","unstructured":"Giaid A, Saleh D: Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995, 333:214\u2013221.","journal-title":"N Engl J Med"},{"key":"27_CR5","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","volume":"328","author":"A Giaid","year":"1993","unstructured":"Giaid A, Yanagisawa M, Langleben D, et al.: Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993, 328:1732\u20131739.","journal-title":"N Engl J Med"},{"key":"27_CR6","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/01.CIR.98.14.1400","volume":"98","author":"JX Yuan","year":"1998","unstructured":"Yuan JX, Aldinger AM, Juhaszova M, et al.: Dysfunctional voltage-gated K+ channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension. Circulation 1998, 98:1400\u20131406.","journal-title":"Circulation"},{"key":"27_CR7","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1161\/01.ATV.20.10.2233","volume":"20","author":"A Kereveur","year":"2000","unstructured":"Kereveur A, Callebert J, Humbert M, et al.: High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy. Arterioscler Thromb Vasc Biol 2000, 20:2233\u20132239.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"27_CR8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00001721-199711000-00006","volume":"8","author":"N Li","year":"1997","unstructured":"Li N, Wallen NH, Ladjevardi M, et al.: Effects of serotonin on platelet activation in whole blood. Blood Coagul Fibrinolysis 1997, 8:517\u2013523.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"27_CR9","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1161\/01.CIR.102.22.2781","volume":"102","author":"S Archer","year":"2000","unstructured":"Archer S, Rich S: Primary pulmonary hypertension: a vascular biology and translational research \u201cwork in progress.\u201d\n                           Circulation 2000, 102:2781\u20132791. Review of relatively current knowledge on molecular pathophysiology of PPH. Current and future treatments are also discussed.","journal-title":"Circulation"},{"key":"27_CR10","doi-asserted-by":"crossref","first-page":"213S","DOI":"10.1378\/chest.114.3_Supplement.213S","volume":"114","author":"M Rabinovitch","year":"1998","unstructured":"Rabinovitch M: Elastase and the pathobiology of unexplained pulmonary hypertension. Chest 1998, 114\n                           ppl:213S-224S. In-depth review of the pathophysiology involved in pulmonary vascular remodeling, with insights into potential therapies.","journal-title":"Chest"},{"key":"27_CR11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/(SICI)1097-4652(199603)166:3<495::AID-JCP4>3.0.CO;2-K","volume":"166","author":"K Thompson","year":"1996","unstructured":"Thompson K, Rabinovitch M: Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular-matrix bound basic fibroblast growth factor. J Cell Physiol 1996, 166:495\u2013505.","journal-title":"J Cell Physiol"},{"key":"27_CR12","first-page":"H1186","volume":"269","author":"NW Morrell","year":"1995","unstructured":"Morrell NW, Morris KG, Stenmark KR: Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. Am J Physiol 1995, 269:H1186\u20131194.","journal-title":"Am J Physiol"},{"key":"27_CR13","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1164\/ajrccm.163.4.2007116","volume":"163","author":"N Nagaya","year":"2001","unstructured":"Nagaya N, Uematsu M, Oya H, et al.: Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension. Am J Respir Crit Care Med 2001, 163:887\u2013891.","journal-title":"Am J Respir Crit Care Med"},{"key":"27_CR14","first-page":"189","volume-title":"Cardiac Problems in Preganacy: Diagnosis and Management of Maternal and Fetal Disease","author":"U Elkayam","year":"1990","unstructured":"Elkayam U, Gleischer N: Primary pulmonary hypertension and pregnancy. In Cardiac Problems in Preganacy: Diagnosis and Management of Maternal and Fetal Disease, edn 2. Edited by Elkayam U, Gleischer N. New York: Alan Liss; 1990:189\u2013198.","edition":"edn 2"},{"key":"27_CR15","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1378\/chest.114.3.787","volume":"114","author":"S Rich","year":"1998","unstructured":"Rich S, Seidlitz M, Dodin E, et al.: The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension. Chest 1998, 114:787\u2013792.","journal-title":"Chest"},{"key":"27_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1056\/NEJM199207093270203","volume":"327","author":"S Rich","year":"1992","unstructured":"Rich S, Kaufmann E, Levy PS: The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992, 327:76\u201381.","journal-title":"N Engl J Med"},{"key":"27_CR17","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.CIR.70.4.580","volume":"70","author":"V Fuster","year":"1984","unstructured":"Fuster V, Steele PM, Edwards WD, et al.: Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 1984, 70:580\u2013587.","journal-title":"Circulation"},{"key":"27_CR18","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0031-3955(05)70121-8","volume":"46","author":"RJ Barst","year":"1999","unstructured":"Barst RJ: Recent advances in the treatment of pediatric pulmonary artery hypertension. Pediatr Clin North Am 1999, 46:331\u2013345. s is a comprehensive review of the medical treatment of children with various forms of pulmonary hypertension.","journal-title":"Pediatr Clin North Am"},{"issue":"suppl2","key":"27_CR19","doi-asserted-by":"crossref","first-page":"17S","DOI":"10.1378\/chest.105.2_Supplement.17S","volume":"105","author":"S Rich","year":"1994","unstructured":"Rich S: The medical treatment of primary pulmonary hypertension. Chest 1994, 105(suppl2):17S-20S.","journal-title":"Chest"},{"key":"27_CR20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-112-7-485","volume":"112","author":"LJ Rubin","year":"1990","unstructured":"Rubin LJ, Mendoza J, Hood M: Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial. Ann Int Med 1990, 112:485\u2013491.","journal-title":"Ann Int Med"},{"key":"27_CR21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1056\/NEJM199602013340504","volume":"334","author":"RJ Barst","year":"1996","unstructured":"Barst RJ, Rubin LJ, Long WA, et al.: A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med 1996, 334:296\u2013302.","journal-title":"N Engl J Med"},{"key":"27_CR22","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/00003246-200003000-00031","volume":"28","author":"B Deb","year":"2000","unstructured":"Deb B, Bradford K, Pearl RG: Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension. Crit Care Med 2000, 28:795\u2013799.","journal-title":"Crit Care Med"},{"key":"27_CR23","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S0003-4975(97)00011-8","volume":"63","author":"EP Chen","year":"1997","unstructured":"Chen EP, Bittner HB, Davis RD Jr, et al.: Milrinone improves pulmonary hemodynamics and right ventricular function in chronic pulmonary hypertension. Ann Thorac Surg 1997, 63:814\u2013821.","journal-title":"Ann Thorac Surg"},{"key":"27_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1058-9813(01)00076-5","volume":"12","author":"TL Spray","year":"2001","unstructured":"Spray TL, Bridges ND: Lung transplantation for pediatric pulmonary hypertension. Prog Pediatr Cardio 2001, 12:319\u2013325. This is a comprehensive review of the issues surrounding lung transplanation as a therapy for pulmonary hypertension in children.","journal-title":"Prog Pediatr Cardio"},{"key":"27_CR25","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/clinids\/20.2.394","volume":"20","author":"AM Apalsch","year":"1995","unstructured":"Apalsch AM, Green M, Ledesma-Medina J, et al.: Parainfluenza and influenza virus infections in pediatric organ transplant recipients. Clin Infect Dis 1995, 20:394\u2013399.","journal-title":"Clin Infect Dis"},{"key":"27_CR26","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0022-5223(98)70168-0","volume":"116","author":"ND Bridges","year":"1998","unstructured":"Bridges ND, Spray TL, Collins MH, et al.: Adenovirus infection in the lung results in graft failure after lung transplantation. J Thorac Cardiovasc Surg 1998, 116:617\u2013623.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"27_CR27","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7326\/0003-4819-124-9-199605010-00006","volume":"124","author":"H Olschewski","year":"1996","unstructured":"Olschewski H, Walmrath D, Schermuly R, et al.: Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med 1996, 124:820\u2013824.","journal-title":"Ann Intern Med"},{"key":"27_CR28","first-page":"197","volume":"27","author":"T Saji","year":"1996","unstructured":"Saji T, Ozawa Y, Nakayama T, et al.: Short- and longterm effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension [in Japanese]. J Cardiol 1996, 27:197\u2013205.","journal-title":"J Cardiol"},{"issue":"suppl2","key":"27_CR29","first-page":"II","volume":"102","author":"RJ Barst","year":"2000","unstructured":"Barst RJ, Simonneau G, Rich S, et al., and the Uniprost PAH Study Group: Efficacy and safety of chronic subcutaneous infusion of UT-15 in pulmonary arterial hypertension [abstract]. Circulation 2000, 102(suppl2):II-100.","journal-title":"Circulation"},{"key":"27_CR30","unstructured":"Christman BW, Barst RJ, Dias VC, et al.: Effects of a thromboxane synthetase inhibitor\/receptor antagonist (TSI\/TRA) on endogenous prostanoid synthesis, exercise capacity, and hemodynamics in patients with primary pulmonary hypertension [abstract]. American Heart Association Scientific Sessions 2000. New Orleans, LA; November 12\u201315, 200."},{"key":"27_CR31","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S1053-2498(00)00606-9","volume":"20","author":"R Channick","year":"2001","unstructured":"Channick R, Badesch DB, Tapson VF, et al.: Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary hypertension: a placebocontrolled study. J Heart Lung Transplant 2001, 20:262\u2013263.","journal-title":"J Heart Lung Transplant"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-001-0027-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11936-001-0027-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-001-0027-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-001-0027-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T11:03:43Z","timestamp":1659092623000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11936-001-0027-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["27"],"URL":"https:\/\/doi.org\/10.1007\/s11936-001-0027-4","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,10]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}